Neural Correlates of Symptom Improvement Following Stimulant Treatment in Adults with Attention-Deficit/Hyperactivity Disorder [0.03%]
注意缺陷多动障碍成人患者刺激治疗后症状改善的神经相关性研究
Zhen Yang,Clare Kelly,Francisco X Castellanos et al.
Zhen Yang et al.
Objective: The purposes of this study were to examine the impact of 3 weeks of amphetamine administration on intrinsic connectome-wide connectivity patterns in adults with attention-deficit/hyperactivity disorder (ADHD) a...
Randomized Controlled Trial
Journal of child and adolescent psychopharmacology. 2016 Aug;26(6):527-36. DOI:10.1089/cap.2015.0243 2016
Intrinsic Brain Connectivity Following Long-Term Treatment with Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder [0.03%]
注意缺陷多动障碍儿童长期服用哌甲酯后的内在脑连接性变化研究
Lucas Battel,Renata R Kieling,Christian Kieling et al.
Lucas Battel et al.
Introduction: Although widely used for the treatment of attention-deficit/hyperactivity disorder (ADHD) across the life span, the effects of methylphenidate (MPH) on the brain are not completely understood. Functional neu...
Placebo Response in Pediatric Anxiety Disorders: Implications for Clinical Trial Design and Interpretation [0.03%]
儿科焦虑障碍的安慰剂反应：对临床试验设计和解释的影响
Eric T Dobson,Jeffrey R Strawn
Eric T Dobson
Objectives: The characterization and prediction of placebo response in clinical trials of youth with anxiety disorders have received little attention, despite the critical effects of placebo response rate on the success o...
N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial [0.03%]
儿童抽动障碍的治疗：N-乙酰半胱氨酸附加疗法的随机双盲安慰剂对照试验
Michael H Bloch,Kaitlyn E Panza,Alisa Yaffa et al.
Michael H Bloch et al.
Background: Current pharmacological treatments for Tourette Syndrome (TS), such as antipsychotic agents and α-2 agonists, are moderately effective in the treatment of tics, but have substantial side effects that limit th...
Randomized Controlled Trial
Journal of child and adolescent psychopharmacology. 2016 May;26(4):327-34. DOI:10.1089/cap.2015.0109 2016
Venkata Kolli,Hind Mary,Blanca Garcia-Delgar et al.
Venkata Kolli et al.
Disruptive Mood Dysregulation Disorder: Where Did It Come from and Where Is It Going [0.03%]
儿童情绪紊乱障碍的来龙去脉
Gabrielle A Carlson
Gabrielle A Carlson
From the Editor-in-Chief's Desk [0.03%]
主编来信
Harold S Koplewicz
Harold S Koplewicz
Abnormal Cortical Plasticity in Youth with Autism Spectrum Disorder: A Transcranial Magnetic Stimulation Case-Control Pilot Study [0.03%]
自闭症谱系障碍患者异常的大脑皮层可塑性：经颅磁刺激病例对照研究
Ernest V Pedapati,Donald L Gilbert,Craig A Erickson et al.
Ernest V Pedapati et al.
Objective: This case-control study investigated the use of a low-intensity repetitive transcranial magnetic stimulation (rTMS) protocol to measure motor cortex (M1) plasticity in youth with autism spectrum disorder (ASD) ...
Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale [0.03%]
关于兴奋剂药物在认知、动机和情绪方面不良事件的知觉报告：定性调查以及药物与认知评估量表项目的产生
Hanna Kovshoff,Tobias Banaschewski,Jan K Buitelaar et al.
Hanna Kovshoff et al.
Objective: There is no questionnaire to specifically monitor perceived adverse events of methylphenidate (MPH) on cognition, motivation, and mood. The current study therefore had two goals. First, to harvest accounts of s...
Clozapine for Drug-Refractory Irritability in Individuals with Developmental Disability [0.03%]
用于发育障碍患者的难治性易激惹的氯氮平治疗
Logan K Wink,Ismail Badran,Ernest V Pedapati et al.
Logan K Wink et al.
Objectives: In this case series, we describe the acute clinical impact and tolerability of rapid titration of clozapine for treatment of refractory irritability in five hospitalized youth with developmental disability. We...